TN2011000018A1 - Pharmaceutical formulations containing dopamine receptor ligands - Google Patents

Pharmaceutical formulations containing dopamine receptor ligands

Info

Publication number
TN2011000018A1
TN2011000018A1 TN2011000018A TN2011000018A TN2011000018A1 TN 2011000018 A1 TN2011000018 A1 TN 2011000018A1 TN 2011000018 A TN2011000018 A TN 2011000018A TN 2011000018 A TN2011000018 A TN 2011000018A TN 2011000018 A1 TN2011000018 A1 TN 2011000018A1
Authority
TN
Tunisia
Prior art keywords
receptor ligands
dopamine receptor
pharmaceutical formulations
formulations containing
containing dopamine
Prior art date
Application number
TN2011000018A
Other languages
French (fr)
Inventor
Mahendra G Dedhiya
Anil Chettry
Ranajoy Sarkar
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/050835 external-priority patent/WO2010009309A1/en
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of TN2011000018A1 publication Critical patent/TN2011000018A1/en

Links

Abstract

The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.
TN2011000018A 2009-07-16 2011-01-14 Pharmaceutical formulations containing dopamine receptor ligands TN2011000018A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/050835 WO2010009309A1 (en) 2008-07-16 2009-07-16 Pharmaceutical formulations containing dopamine receptor ligands

Publications (1)

Publication Number Publication Date
TN2011000018A1 true TN2011000018A1 (en) 2012-09-05

Family

ID=55024334

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000018A TN2011000018A1 (en) 2009-07-16 2011-01-14 Pharmaceutical formulations containing dopamine receptor ligands

Country Status (1)

Country Link
TN (1) TN2011000018A1 (en)

Similar Documents

Publication Publication Date Title
MY156288A (en) Pharmaceutical formulations containing dopamine receptor ligands.
IN2012MN02591A (en)
MY161088A (en) Agonists of gpr40
IN2012DN06720A (en)
MX2020012825A (en) Multicyclic compounds and methods of use thereof.
IN2014MN00948A (en)
IN2014MN00986A (en)
MY157124A (en) Substituted imidazopyridinyl-aminopyridine compounds
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
MX2013001677A (en) Stable formulations of linaclotide.
MX349004B (en) New compounds.
ZA201100034B (en) Pharmaceutical compositions for treatment of parkinson's disease
EP2582676A4 (en) Tetrahydroquinoline amide m1 receptor positive allosteric modulators
MY148948A (en) Catecholamine derivatives and prodrugs thereof
GB2511685A (en) Muscarinic m1 receptor agonists
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MY156302A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES
MX2011007267A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
MX344846B (en) Combination of active loaded granules with additional actives.
PH12015500823A1 (en) Modified release formulations for oprozomib
MX342119B (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators.
MX2011008126A (en) Substituted indole compounds as bradykinin receptor 1 modulators.
MX2015005312A (en) 1 h-indole-3-carboxamide derivatives and use thereof as p2y12 antagonists.
MX2013002295A (en) Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators.
TN2011000018A1 (en) Pharmaceutical formulations containing dopamine receptor ligands